Cyclopharm Lodges NDA for Technegas with the USFDA
Filed with ASX · · 2 pages · English
Story so far
Earlier from Cyclopharm
- Cyclopharm Company Update
- CYC Institutional Placement - Premium To Share Price
- Agreement to utilise Cyclotron facility assets
- Pause in Trading
- CYC Business Update
Later from Cyclopharm
- USFDA Grants Cyclopharm USD$2.9m Application Fee Waiver
- Technegas Approved in Russia
- USFDA Approval to File Received for Technegas
- CYC 1H2020 Business Update
- Technegas USA Trial Successfully Meets Primary Endpoint
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm